1218973

Orion Corporation, Orion Pharma — FEI 3003073605

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 2, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Espoo (Finland)

Additional Details

Mutual Recognition Agreement (MRA)